Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES ZYDUS LIFESCIENCES SUVEN LIFE SCIENCES/
ZYDUS LIFESCIENCES
 
P/E (TTM) x -20.5 34.2 - View Chart
P/BV x 5.8 5.8 100.3% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 SUVEN LIFE SCIENCES   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
ZYDUS LIFESCIENCES
Mar-23
SUVEN LIFE SCIENCES/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs94495 18.9%   
Low Rs45319 14.1%   
Sales per share (Unadj.) Rs0.6170.3 0.4%  
Earnings per share (Unadj.) Rs-5.419.8 -27.4%  
Cash flow per share (Unadj.) Rs-5.126.9 -19.0%  
Dividends per share (Unadj.) Rs06.00 0.0%  
Avg Dividend yield %01.5 0.0%  
Book value per share (Unadj.) Rs17.2173.0 9.9%  
Shares outstanding (eoy) m218.071,012.20 21.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.82.4 4,674.1%   
Avg P/E ratio x-12.820.6 -62.1%  
P/CF ratio (eoy) x-13.515.1 -89.5%  
Price / Book Value ratio x4.02.4 171.3%  
Dividend payout %030.3 -0.0%   
Avg Mkt Cap Rs m15,131412,144 3.7%   
No. of employees `000NANA-   
Total wages/salary Rs m18624,564 0.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m135172,374 0.1%  
Other income Rs m844,746 1.8%   
Total revenues Rs m220177,120 0.1%   
Gross profit Rs m-1,19629,677 -4.0%  
Depreciation Rs m657,227 0.9%   
Interest Rs m51,299 0.4%   
Profit before tax Rs m-1,18325,897 -4.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m05,878 0.0%   
Profit after tax Rs m-1,18320,019 -5.9%  
Gross profit margin %-883.617.2 -5,132.5%  
Effective tax rate %022.7 -0.0%   
Net profit margin %-873.511.6 -7,521.6%  
BALANCE SHEET DATA
Current assets Rs m3,455100,082 3.5%   
Current liabilities Rs m1,05055,267 1.9%   
Net working cap to sales %1,776.026.0 6,831.2%  
Current ratio x3.31.8 181.7%  
Inventory Days Days3,94850 7,849.7%  
Debtors Days Days21894 232.7%  
Net fixed assets Rs m1,373144,776 0.9%   
Share capital Rs m2181,012 21.5%   
"Free" reserves Rs m3,535174,146 2.0%   
Net worth Rs m3,753175,158 2.1%   
Long term debt Rs m00-   
Total assets Rs m4,828244,940 2.0%  
Interest coverage x-218.820.9 -1,045.2%   
Debt to equity ratio x00-  
Sales to assets ratio x00.7 4.0%   
Return on assets %-24.48.7 -280.2%  
Return on equity %-31.511.4 -275.7%  
Return on capital %-31.415.5 -202.0%  
Exports to sales %40.439.2 103.2%   
Imports to sales %839.811.9 7,046.5%   
Exports (fob) Rs m5567,577 0.1%   
Imports (cif) Rs m1,13720,544 5.5%   
Fx inflow Rs m5567,577 0.1%   
Fx outflow Rs m1,13720,544 5.5%   
Net fx Rs m-1,08247,033 -2.3%   
CASH FLOW
From Operations Rs m-1,03126,888 -3.8%  
From Investments Rs m-2,60611,712 -22.3%  
From Financial Activity Rs m3,955-44,004 -9.0%  
Net Cashflow Rs m317-5,338 -5.9%  

Share Holding

Indian Promoters % 69.6 75.0 92.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 18.0 3.1%  
FIIs % 0.5 5.0 10.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 25.0 121.6%  
Shareholders   74,003 306,495 24.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    MANKIND PHARMA    


More on Suven Life Sciences vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs Cadila Healthcare Share Price Performance

Period Suven Life Sciences Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.30% 0.57% 1.18%
1-Month -2.06% 7.77% -0.75%
1-Year 114.92% 107.52% 61.82%
3-Year CAGR 14.94% 32.30% 18.16%
5-Year CAGR -16.22% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.